Treatment with the immunotherapy dostarlimab showed promising results in a small trial of a dozen rectal cancer patients, according to new research, but further study is needed and it is too early to call it a cure. CNN’s Erin Burnett speaks to Dr. Andrea Cercek, an oncologist at Memorial Sloan Kettering Cancer Center.